Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.
Literal federal measure citations: H.R. 4299, H.R. 5031, S. 3159, H.R. 3164, S. 2426, S.3822